Company Number: SC765261

Analysis Date: 2025-07-20 12:48 UTC

1. Credit Opinion: DECLINE
   ECPM (Dundee) Ltd is a newly incorporated private limited company (April 2023) with dormant status during its first financial period ending April 2024. The company has minimal financial activity, with total assets and shareholders' funds of only £1 and cash at hand of £1. There is no evidence of operating income, profit generation, or any material financial transactions. The lack of trading history and financial substance makes it impossible to assess creditworthiness or repayment capacity. The company’s business activity is classified as residents property management (SIC 98000), but no operational data or revenue is reported. Given these factors, the credit risk is high and the company cannot currently support credit facilities.

2. Financial Strength:
   The balance sheet shows negligible financial strength. The company reports net assets and shareholders’ funds of £1, representing only the nominal share capital. There are no fixed or current assets beyond £1 cash. Current liabilities are effectively zero, but this reflects inactivity rather than a solid financial position. As a dormant entity, the company has no working capital and no retained earnings or reserves. The financial structure is thus extremely weak, providing no cushion against financial distress or downturns.

3. Cash Flow Assessment:
   Cash flow is effectively non-existent. The company holds £1 in cash with no reported trading activity or cash inflows. Without operating cash flow or working capital, the company has no ability to meet operational expenses, debt service, or commercial obligations. The absence of employees and income confirms a zero liquidity profile. Consequently, short-term liquidity risk is critical.

4. Monitoring Points:

• Review subsequent accounts when filed to assess commencement of trading and revenue generation.
• Monitor cash flow patterns and working capital changes once operational.
• Observe director actions and any capital injections or financing arrangements.
• Watch for any overdue filings or adverse changes in company status.
• Assess credit risk anew when meaningful financial data becomes available.